Drug profile · INN
nadofaragene firadenovec
ADSTILADRIN
nadofaragene firadenovec (ADSTILADRIN) is a interferon alpha-2 exogenous gene.
EMA: unknown Antineoplastic and immunomodulating agents (L01) L01XL10
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — nadofaragene firadenovec
- Class
- Antineoplastic and immunomodulating agents (L01)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
nadofaragene firadenovec (ADSTILADRIN) is a interferon alpha-2 exogenous gene.
Key facts
INN nadofaragene firadenovec
Brand ADSTILADRIN
Mechanism Interferon alpha-2 exogenous gene
Target Interferon alpha-2
Therapeutic class Antineoplastic and immunomodulating agents (L01)
ATC code L01XL10
Mechanism of action
Interferon alpha-2 exogenous gene
Primary target: Interferon alpha-2
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | unknown | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is nadofaragene firadenovec?
nadofaragene firadenovec (ADSTILADRIN) is a interferon alpha-2 exogenous gene.
What is the brand name for nadofaragene firadenovec?
ADSTILADRIN is a marketed brand name for nadofaragene firadenovec. Check FDA Drugs@FDA for the current US label holder and prescribing information.